<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Tue, 18 Jun 2013 20:32:51 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>Catalent Pharma Solutions Breaks Ground on a Major Expansion of Its Winchester, Kentucky Controlled Release Manufacturing Facility  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299870&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SOMERSET, N.J.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 12, 2013&lt;/span&gt; /PRNewswire/ --Catalent Pharma Solutions, a leading global drug delivery technology and...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>University of Miami Life Science &amp; Technology Park Finalizes 20,000 SF Lease With DaVita Inc.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299253&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MIAMI May 31, 2013  In the latest example of the University of Miami Life Science &amp; Technology Parks (UMLSTP) appeal among major health care companies looking to tap into the citys growing Health District...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>BASF Starts Up tert. Butylamine Plant in Nanjing, China  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299397&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Nanjing, China  June 7, 2013  BASF today announced the opening of its world-scale tert. Butylamine (tBA) production plant at the Nanjing Chemical Industry Park in China. The plant is wholly-owned by BASF and...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Johnson &amp; Johnson Expands Footprint  in SF; Aims to Hatch Startups, Breakthrough Innovations  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299090&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Johnson &amp; Johnson Innovation Announces Opening of the California Innovation Center&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;MENLO PARK, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 5, 2013&lt;/span&gt; /PRNewswire/ ...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Celerion Expands Belfast Facility With Containment Room to Enable Live Biologics and Vaccine Studies  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130605005041&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, announces the addition of a Containment Room at the Belfast, Northern Ireland, UK facility. The new Containment Room will allow Celerion to develop programs that require...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>InVivos Opens New Breeding Facility in Singapore as Part of Strategic Partnership With Taconic Europe A/S  </title><link /><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;HUDSON, NY and SINGAPORE--(Marketwired - June      04, 2013) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>University of Miami Life Science &amp; Technology Park Inks 20,000 SF Lease With DaVita Inc.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299009&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MIAMI May 31, 2013  In the latest example of the University of Miami Life Science &amp; Technology Parks (UMLSTP) appeal among major health care companies looking to tap into the citys growing Health District...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>PerkinElmer, Inc. Establishes Direct Presence in Turkey  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130603005535&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is opening direct operations in Turkey, headquartered...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;InVitae&lt;/b&gt; Establishes an International Subsidiary and State-of-the-Art Genetic Testing Facility in Chile  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298615&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;SANTIAGO, CHILE--(Marketwired - May       30, 2013) -   &lt;b&gt; &lt;/b&gt;InVitae Corporation announced today the establishment of a South American subsidiary, InVitae Chile SpA, and a partnership...</description><pubDate>Fri, 31 May 2013 12:00:00 AM GMT</pubDate></item><item><title>What Mystery $7 Billion Life Science Company is Moving to SF's Mission Bay? Is it Illumina, Inc.? BioMarin Pharmaceutical Inc.?  </title><link>http://www.bizjournals.com/sanfrancisco/blog/2013/05/illumina-to-light-up-vacant-building.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;San Diego-based Illumina Inc. has leased nearly 100,000 square feet in San Franciscos Mission Bay and plans to open up a major research and development facility there.&lt;br&gt;&lt;br&gt;The gene sequencing company...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Laboratorio Buena Salud&lt;/b&gt; Release: Spanish-First Clinical Lab Opens Patient Testing Centers in Miami and Union City, NJ  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298199&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;ELMWOOD PARK, N.J.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 28, 2013&lt;/span&gt; /PRNewswire/ -- Laboratorio Buena Salud (&lt;a href"http://www.laboratoriobuenasalud...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;The Ezra Company&lt;/b&gt; Negotiates Strong Deal for the Endocrine Society in Its Purchase of 34,000 Square Feet at 2055 L St. NW in Washington, D.C.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298097&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;May 28, 2013 (Washington, D.C.)  Next February, The Endocrine Society, the world's largest and most active organization devoted to research on hormones and the clinical practice of endocrinology, will move...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>AstraZeneca PLC Closes in on Site for New $500 Million Home in Cambridge  </title><link>http://www.reuters.com/article/2013/05/20/us-astrazeneca-cambridge-idUSBRE94J0G120130520</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said. Moving research and...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>First ARKRAY, Inc. Overseas R&amp;D Center to be Incubated in Singapore's Institute of Bioengineering and Nanotechnology  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297607&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Singapore, May 22, 2013  ARKRAY, Inc. has set up its first Asian research center outside Japan in Singapores Institute of Bioengineering and Nanotechnology (IBN). The company will invest $9.1 million over...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>ClinTec GmbH Expands Further in MENA Region With Proposed Opening of Istanbul Office  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297393&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;21 May 2013: ClinTec International, a global CRO with a presence in over 40 countries worldwide, today announced its intention to formally open an office in Istanbul, Turkey. The office will not only...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>BioDuro, LLC Opens State-of-the-Art Discovery Lab in Shanghai  </title><link>http://www.chinabiotoday.com/articles/20130516_1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WILMINGTON, N.C.--(BUSINESS WIRE)--BioDuro, A PPD Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Quantum Materials Corp&lt;/b&gt; Moves &lt;b&gt;Quantum Dot Labs&lt;/b&gt; to STAR Park, San Marcos, TX  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296583&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; &lt;div class"xn-content"&gt;&lt;p /&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SAN MARCOS, Texas&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 14, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href"http://www.qmcdots.com/" target"_blank"&gt;Quantum Materials...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Lloyd's Register&lt;/b&gt; and A*STAR &lt;b&gt;IHPC&lt;/b&gt; Open Joint Laboratory to Pursue R&amp;D on Technical Innovations in the Energy and Marine Industries  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296258&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;1.         Singapore, 10 May 2013  Lloyds Register (LR) and A*STARs Institute of High Performance Computing (IHPC) have officially opened a joint laboratory, which will deliver innovative technological solutions...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>LabConnect, LLC Expands North American Headquarters in Seattle  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130508005204&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;SEATTLE--(BUSINESS WIRE)--The success of LabConnects Scientific Operations Support (SciOps) team and overall company growth are behind its move to larger quarters in Seattles historic district.&lt;br&gt;&lt;br&gt;...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Greenphire&lt;/b&gt; Announces New London Office to Facilitate Expansion in Europe  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295605&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;King of Prussia, PA  Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced an expansion into the European market with the opening of its London office. ...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Harlan Laboratories, Inc. Continues Global Growth with Major Expansion of North American Facilities  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295696&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;INDIANAPOLIS&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 7, 2013&lt;/span&gt; /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Neurosearch A/S Sells Land and Building  </title><link>http://www.globenewswire.com/news-release/2013/05/06/544507/0/en/NeuroSearch-A-S-sells-land-and-building.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Today, NeuroSearch (NEUR) signed an agreement with PKA regarding the sale of the company's land and building effective from 1 June 2013 at a cash price of DKK 112.5 million. The agreement is final and unconditional...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Tianyin Pharmaceutical Co, Inc.'s Qionglai Facility (QLF) Construction Completed  </title><link>http://www.biospace.com/news_story.aspx?StoryID=294987&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHENGDU, China&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 1, 2013&lt;/span&gt; /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company...</description><pubDate>Wed, 01 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Unions Fight AstraZeneca PLC Plans to Move R&amp;D Base South  </title><link>http://www.independent.co.uk/news/business/news/unions-fight-astra-plans-to-move-rd-base-south-8591975.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Union leaders will meet executives at AstraZeneca today to try to convince Britain's second-biggest drugmaker to reverse plans to close its R&amp;D site in Cheshire and move almost 2,000 jobs. AstraZeneca...</description><pubDate>Tue, 30 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Eisai Company, Ltd. to Establish New Parenteral Facility in China  </title><link>http://www.chinabiotoday.com/articles/20130425</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;April 25, 2013-Eisai Co., Ltd. (Headquarters: Tokyo, President &amp; CEO: Haruo Naito, "Eisai") announced today that it has decided to establish a new parenteral facility (below, "New Plant") on a lot retained...</description><pubDate>Thu, 25 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Hemarina&lt;/b&gt; Opens Office in Boston  </title><link>http://www.biospace.com/news_story.aspx?StoryID=294223&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Morlaix, France - 04/23/2013  HEMARINA, the French based Biotechnology Company, today announced its establishment in Boston, Massachusetts USA thru the incorporation of Hemarina Inc. on March 15th, 201...</description><pubDate>Wed, 24 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;BioOutsource&lt;/b&gt; Opens New Facility in Cambridge, Massachusetts  </title><link>http://www.biospace.com/news_story.aspx?StoryID=294145&amp;full=1</link><description>Chicago, IL, USA and Glasgow, Scotland, UK, April 23, 2013 / B3C newswire /  BioOutsource Ltd. (BioOutsource), a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, today announced the opening of a new facility in Cambridge, Massachusetts, the companys first in the United States. The company plans to draw on its unparalleled depth of experience in...</description><pubDate>Tue, 23 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Novo Nordisk A/S Unveils New U.S. Headquarters  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293936&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;source"news-signup""&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;PLAINSBORO, N.J.&lt;/span&gt;, &lt;span class"xn-chron"&gt;April 19, 2013&lt;/span&gt; /PRNewswire/ -- Advancing its commitment to patients and &lt;span class"xn-location...</description><pubDate>Mon, 22 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Merck &amp; Co., Inc. Opens New Manufacturing Facility in Hangzhou, China  </title><link>http://www.chinabiotoday.com/articles/20130417_2</link><description>April 16, 2013 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the opening of its new pharmaceutical manufacturing facility in Hangzhou, China. The facility, located in the Hangzhou Economic and Technology Area (HEDA), will package Merck medicines for China and the Asia Pacific region and will become a critical part of Mercks global supply chain. &lt;/p&gt;&lt;p&gt;...</description><pubDate>Thu, 18 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pharmascience Inc. Inaugurates New Dorval Distribution Center to Centralize Shipments to Customers in Canada and 60 Countries Around the World  </title><link>http://www.newswire.ca/en/story/1147309/pharmascience-inaugurates-new-dorval-distribution-centre-to-centralize-shipments-to-customers-in-canada-and-60-countries-around-the-world</link><description>MONTREAL, April 17, 2013 /CNW/ - Montreal's Pharmascience Inc., Canada's 10th largest pharmaceutical company and third largest maker of generic drugs, today inaugurated a new, state-of-the-art distribution centre on 55th Avenue in Dorval, representing an investment of $4 million.</description><pubDate>Wed, 17 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Covance Inc. Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increased Asia Pacific Focus  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293395&amp;full=1</link><description>Princeton, N.J., April 16, 2013  Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced completion of the expansion of its central laboratory facility in Singapore to enhance the companys current service offerings and position it to meet current and future growth of drug development in the Asia Pacific region. The expansion is the latest in Covances continued...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Cromos Pharma&lt;/b&gt; Opens an Office in the Republic of Georgia  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293404&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;MOSCOW--(Marketwired - April     16, 2013) -   Cromos Pharma, an international full service contract research organization (CRO), announced today that it opened an office in the Republic of Georgia.&lt;p&gt;"Georgia is a very important location for Cromos Pharma," noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. "Some of the unique qualities of Georgia are...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>First Turf Marks New Era for  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293391&amp;full=1</link><description>April 16, 2013 -- The first turf has been cut on Norwich Research Park marking the start of its transformation from a world-class centre of research to a next generation research and innovation park.  The new Centrum building will be the hub of the new campus, with meeting spaces to facilitate interaction between commercial and academic researchers, and accommodation for larger commercial organisations...</description><pubDate>Tue, 16 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Fluidigm Corporation Release: Singapore Single-Cell Research Centre Opens Door for Asian Biological Discoveries  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130411005567&amp;newsLang=en</link><description>SINGAPORE &amp; SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight...</description><pubDate>Fri, 12 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Dr. Reddy's Laboratories Ltd.'s to Open R&amp;D Center in New Jersey  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292923&amp;full=1</link><description>HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddys Laboratories (NYSE: RDY) today announced plans to relocate their North America Headquarters and establish a R&amp;D Center in Princeton, New Jersey. Dr. Reddys, represented by Jones Lang LaSalle, has entered into two lease agreements for a 75,500 square foot office facility and a 31,000 square foot office/lab at 107 College Road East and 303 College Road...</description><pubDate>Wed, 10 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. R&amp;D Building Demolition May be Delayed  </title><link>http://www.theday.com/article/20130408/NWS01/130409584/1017</link><description>The City Council unanimously approved an emergency ordinance on Monday that is designed to delay by at least three months the planned demolition of Pfizer's former research headquarters. Viewed as a stalling tactic by some, the "building preservation" ordinance is aimed at providing time for Pfizer, or another demolition applicant of comparable size, to explore alternatives to demolition while addressing...</description><pubDate>Tue, 09 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;TranScrip&lt;/b&gt; Partners Announce U.S. Expansion  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292573&amp;full=1</link><description>Philadelphia, 5th April 2013  TranScrip Partners, the rapidly growing, cutting-edge contract organisation today announced the formation of its US office, TranScrip Partners (USA) LLC. The US branch of TranScrip Partners will be led by Glenn Tillotson, a pharmaceutical expert with 25 years industry experience and a successful track record in drug development and life cycle management. The expansion...</description><pubDate>Fri, 05 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pall Corporation to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130404005764&amp;newsLang=en</link><description>PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today confirmed plans for a state-ofthe-art Life Sciences Centre of Excellence at its new Harbourgate site in Portsmouth in the United Kingdom (UK). The Centre of Excellence (COE), which will open in mid 2013, will offer a full suite of capabilities including cell culture...</description><pubDate>Thu, 04 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Stuns Officials, Will Demolish Building 118  </title><link>http://www.theday.com/article/20130327/BIZ02/130329658/1017</link><description>Pfizer Inc.'s decision Wednesday to tear down the company's sprawling former research headquarters off Eastern Point Road stunned local and state officials who had invested thousands of hours trying to reuse the space to spur economic development in the region. Officials involved in the negotiations said last-minute obstacles thrown up by Pfizer after a major developer had offered to purchase the ...</description><pubDate>Mon, 01 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Cellular Dynamics International Opens Facility in California, Leasing Space From the Buck Institute for Age Research to Derive and Bank Human Induced Pluripotent Stem Cells  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292024&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;MADISON, Wis.&lt;/span&gt;, &lt;span class"xn-chron"&gt;April 1, 2013&lt;/span&gt; /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that the company is opening a facility in &lt;span class"xn-location"&gt;Novato, Calif&lt;/span&gt;, leasing space from the &lt;a href"http://www.buckinstitute.org/" target"_blank"&gt;Buck Institute for Research on Aging&lt;/a&gt;...</description><pubDate>Mon, 01 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline $91 Million Flu Vaccine Center Coming to Texas  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291663&amp;full=1</link><description>AUSTIN, Texas and PHILADELPHIA, March 26, 2013 /PRNewswire/ -- GlaxoSmithKline plc (GSK) and The Texas A&amp;M University System announced today that the U.S. Department of Health and Human Services (DHHS) has approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor of the Center for Innovation in Advanced Development and Manufacturing (CIADM) in Bryan-College...</description><pubDate>Wed, 27 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;CPR Pharma Services&lt;/b&gt; New Facility Strengthens Asia's Clinical Trials Offering  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291569&amp;full=1</link><description>Having launched Singapores first bio-analytical laboratory last year, CPR Pharma Services continues to make the Asia-Pacific (APAC) region a global hub for clinical trials by launching  its ligand binding  assay service for large molecules to complement its existing lab services focused on small molecules.&lt;/p&gt;&lt;p&gt;The new laboratory, in Adelaide, Australia now offers best practice ligand binding...</description><pubDate>Tue, 26 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;BioMed Realty&lt;/b&gt; to Lease 204,900 Square Feet to Life Technologies at the Science Center at Oyster Point in South San Francisco  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291220&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 20, 2013&lt;/span&gt; /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of two new leases for 15 years with Life Technologies Corporation (NASDAQ: LIFE) at its Science Center at Oyster Point property in the heart of the &lt;span class"xn-location"&gt;South San Francisco, California...</description><pubDate>Thu, 21 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Bioheart, Inc. Expands Center of Excellence Program  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290935&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;SUNRISE, FL--(Marketwire - March     19, 2013) -   Bioheart, Inc. (OTCQB: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerBHRT"&gt;BHRT&lt;/a&gt;) announced today that it has expanded its Center of Excellence program to include a clinical site in Jamaica with the American Stem Cell and Anti-Aging Center. This site is in addition to the existing centers in Turkey, the Czech Republic...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Automation GT&lt;/b&gt; to Move Headquarters to Carlsbad  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291023&amp;full=1</link><description>Automation GT has announced it is moving its headquarters to Carlsbad, the largest Life Sciences hub in Southern California. Founded in 2002, the designer and manufacturer of custom automation solutions has outgrown its location in Escondido and is now upgrading to a 13,000 square foot campus. &lt;/p&gt;&lt;p&gt;The Palomar Oaks Technology Park building will provide ample housing for Automation GTs...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Eli Lilly and Company Opens China IT Center to Facilitate Collaboration With Partners  </title><link>http://www.chinabiotoday.com/articles/20130319</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;March 19, 2013 -- Eli Lilly opened the Lilly Global IT Innovations Lab in Dalian yesterday. The lab will provide a platform from which Lilly and its drug development partners  in China and across the globe  can collaborate freely. Lilly said the Global IT Innovations Lab would support its China investment and its operations globally. More details....&lt;/p&gt;&lt;p&gt;Stock...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Johnson &amp; Johnson Opens Innovation Center in London  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290358&amp;full=1</link><description>London (13 March 2013)  Johnson &amp; Johnson today announced the opening of the Johnson &amp; Johnson Innovation centre in London, one of four regional hubs being established this year in the worlds leading innovation hotspots.  A part of Johnson &amp; Johnson Innovation, the goal of the London innovation centre is to accelerate the best early stage science in the world and advance the development of new healthcare...</description><pubDate>Wed, 13 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Auction - BioSurplus Moving From Fremont to South San Francisco  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130312006436&amp;newsLang=en</link><description>FREMONT, Calif.--(BUSINESS WIRE)--BioSurplus announced today that it is moving its Fremont lab equipment showroom to a new 22,000 square foot facility in South San Francisco. In preparation for the move, the company will hold an online auction from March 14 to 21; all equipment in the Fremont showroom will be made available at deep discounts. FREMONT, Calif.--(BUSINESS WIRE)--BioSurplus announced today...</description><pubDate>Wed, 13 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Actavis to Close Research Unit in Malta  </title><link>http://www.timesofmalta.com/articles/view/20130308/local/Pharmaceutical-firm-to-close-research-unit.460684</link><description>Pharmaceutical company Actavis has decided to close down the research and development department in Bulebel, where 60 employees work. While insisting that no jobs had been terminated yet, Actavis Maltas managing director, Sergio Vella, explained that, following the acquisition by US giant Watson, the company ended up with many R&amp;D units worldwide, creating duplication of work. Last December, the company...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Scheer Partners, Inc. Represents USDS in 10,000-Square-Foot Lease at 9712 Medical Center Drive in Rockville  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290115&amp;full=1</link><description>Rockville, MD (March 11, 2013)  A private, independent review body for medical diagnostics is gearing up to grow from one of Montgomery Countys Innovation Centers to a larger space in the County.&lt;/p&gt;&lt;p&gt;Scheer Partners, the leading provider of fully integrated commercial real estate services for the health science industry in the Washington and Baltimore metropolitan areas, announces today that...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Horizon Discovery Ltd. Establishes Two New Centers of Excellence in Cambridge, UK  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290125&amp;full=1</link><description>Cambridge, UK, 11 March 2013: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has established two new Centers of Excellence (CoEs) for gene editing in Cambridge, UK. The new Centers are at the Gurdon Institute, Cambridge University with Prof. Steve Jackson FRS, and the Cambridge Institute for Medical Research...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Marken (Formerly known as Marken Time Critical) Opens Pharmaceutical Depot in Beijing China  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289795&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RESEARCH TRIANGLE PARK, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 7, 2013&lt;/span&gt; /PRNewswire/ -- Marken announced today the completion of its new pharmaceutical depot in &lt;span class"xn-location"&gt;Beijing&lt;/span&gt;, China.  The new facility which provides 850 m&lt;sup&gt;2&lt;/sup&gt; of GMP compliant space for temperature controlled storage as well as distribution...</description><pubDate>Thu, 07 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>MicroVention, Inc.'s New Manufacturing Plant Facility in Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289667&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;TUSTIN, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 6, 2013&lt;/span&gt; /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced that its new manufacturing facility in &lt;span class"xn-location"&gt;San Jose, Costa Rica&lt;/span&gt; is now open.  The Company also held a Grand Opening Ceremony today to commemorate this exciting...</description><pubDate>Wed, 06 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Ashland Inc.  to Expand Pharmaceutical Center of Excellence in Delaware  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289688&amp;full=1</link><description>WILMINGTON, Del.  Ashland Inc. (NYSE: ASH) today announced plans to expand its pharmaceutical research and development Center of Excellence at the Ashland Research Center in Wilmington. Ashland will be expanding its existing capabilities to include formulation development and Good Manufacturing Processes (GMP) contract manufacturing services for solid dispersions and oral solid dosages. To support...</description><pubDate>Wed, 06 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Onyx Pharmaceuticals, Inc. to Extend South San Francisco Campus Again  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289348&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;PASADENA, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 4, 2013&lt;/span&gt; /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the largest and leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce that Onyx Pharmaceuticals, Inc., a global commercial...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Scheer Partners, Inc. Represents Macrogen in 6,800-Square-Foot Lease at 1330 Piccard Drive in Rockville  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289544&amp;full=1</link><description>Rockville, MD (March 5, 2013)  One of the top DNA-sequencing companies in the world has expanded the size of its local R&amp;D facility by moving it to a new site in Montgomery County.&lt;/p&gt;&lt;p&gt;Scheer Partners, the leading provider of fully integrated commercial real estate services for the health science industry in the Washington and Baltimore metropolitan areas, announces today that it has negotiated...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Pharmatest Services Ltd&lt;/b&gt; Opens U.S. Sales Office in Cambridge, Mass.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289546&amp;full=1</link><description>CAMBRIDGE, Mass. / TURKU, Finland  March 5, 2013  Finnish company Pharmatest Services Ltd (Pharmatest) announced today that it has opened a new U.S. sales office in Cambridge, Mass., near Boston. The new office, located in the Cambridge Innovation Center (CIC) in Kendall Square, will provide an excellent opportunity for Pharmatest to contact and serve customers in the Massachusetts area.&lt;/p&gt;&lt;p...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Pfizer Inc. Lays Foundation Stone for Factory in Saudi Arabia  </title><link>http://www.saudigazette.com.sa/index.cfm?method=home.regcon&amp;contentid=20130301154956</link><description>Pfizer Inc., one of the largest pharmaceutical companies in the world, announced Wednesday that it has laid the foundation stone for its drug factory which will be constructed in the King Abdullah Economic City (KAEC), the first in the Gulf region, according to the Saudi Press Agency. The foundation stone was laid during an event held here Wednesday and attended by the secretary general of the Economic...</description><pubDate>Fri, 01 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Immunotech Laboratories Relocates to New Research &amp; Development Laboratory Facility  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289168&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;PASADENA, CA--(Marketwire - March     01, 2013) -   &lt;b&gt; Immunotech Laboratories, Inc. &lt;/b&gt;(PINKSHEETS: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerIMMB"&gt;IMMB&lt;/a&gt;) today announced the company has relocated to a new Research &amp;amp; Development Lab facility in Monrovia, California.&lt;p&gt;The new facility incorporates more laboratory use of the actual facility than the...</description><pubDate>Fri, 01 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Polaris of San Diego to Build $50 Million Facility in Chengdu  </title><link>http://www.chinabiotoday.com/articles/20130228_2</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;February 28, 2013 -- Polaris Group, a San Diego biotech with multinational collaborations, will build a $50 million drug manufacturing facility in Chengdu, the capital of Sichuan Province in Southwest China. Polaris is currently conducting a global Phase III trial of a biotech drug for hepatocellular cancer. Previously, Polaris intended to build the facility in Taiwan...</description><pubDate>Fri, 01 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Pharmatek Laboratories, Inc. Announces Facility Expansion  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289017&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;Feb. 27, 2013&lt;/span&gt; /PRNewswire/ -- Pharmatek, a contract development and manufacturing organization supporting the pharmaceutical industry, announced plans to expand its GMP facilities. The expansion comes at a time when the Company is experiencing strong growth and increasing global demand for its services...</description><pubDate>Thu, 28 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Beijing Double-Crane&lt;/b&gt; to Build $43 Million Shanghai Plant  </title><link>http://www.chinabiotoday.com/articles/20130221_1</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;February 21, 2013 -- Beijing Double-Crane Pharmaceutical will invest 271 million RMB ($43 million) to build a fluid infusion manufacturing facility in Shanghais Jinshan Development Park. The plant will be operated by a subsidiary of Double-Crane, Shanghai Changzheng Fumin Jinshan Pharmaceutical Co. More details....&lt;/p&gt;&lt;p&gt;Stock Symbol: (SHE: 600062)&lt;/p&gt;</description><pubDate>Fri, 22 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Janssen Pharmaceutical K.K. Opens R&amp;D Center in Shanghai  </title><link>http://www.chinabiotoday.com/articles/20130205_1</link><description>by Richard Daverman, PhD and Henry Ye&lt;/p&gt;&lt;p&gt;February 5, 2013 -- Janssen Pharmaceutical, a division of Johnson &amp; Johnson, has officially opened its China R&amp;D Center in Shanghai Fenglin Life Science Park. The lab is located in the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. It will collaborate with the SIOC, Fudan University School of Medicine and other institutions to conduct...</description><pubDate>Wed, 06 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Janssen Labs&lt;/b&gt; at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups  </title><link>http://www.biospace.com/news_story.aspx?StoryID=286728&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;Feb. 5, 2013&lt;/span&gt; /PRNewswire/ -- Janssen Labs at &lt;span class"xn-location"&gt;San Diego&lt;/span&gt;, part of Janssen Research &amp;amp; Development, LLC (Janssen), today announced the addition of a Concept Lab and an Open Collaboration Space. The Concept Lab is a shared laboratory that offers entrepreneurs affordable...</description><pubDate>Tue, 05 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Procter &amp; Gamble, Teva Pharmaceutical Industries Limited Break Ground on $90 Million Plant  </title><link>http://www.bizjournals.com/cincinnati/blog/2013/01/procter-gamble-teva-break-ground.html?ana=otj</link><description>Procter &amp; Gamble Co. and Israel-based Teva Pharmaceuticals broke ground on a $90 million joint venture facility in the Indian state of Gujarat, the Times of India reported. The plant will make consumer health and over-the-counter products, including inhalers, throat drops and cough syrups under the Vicks brand, in the city of Sanand, as the Business Courier previously reported. The JV company, with...</description><pubDate>Thu, 31 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Siemens Canada&lt;/b&gt; Opens Smart Grid Centre of Competence in Fredericton, New Brunswick  </title><link>http://www.biospace.com/news_story.aspx?StoryID=286295&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;b&gt;New office and hiring support multi-year partnership with NB Power&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;span class"xn-location"&gt;FREDERICTON, NB&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 31, 2013&lt;/span&gt; /CNW/ - &lt;span class"xn-location"&gt;New Brunswick&lt;/span&gt; Premier David Alward, NB Power CEO Getan Thomas and Siemens Canada CEO &lt;span class"xn-person"&gt;Robert Hardt&lt;/span&gt; were among those in attendance...</description><pubDate>Thu, 31 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Pluristem Therapeutics Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility  </title><link>http://www.globenewswire.com/news-release/2013/01/30/519418/10019870/en/Pluristem-Takes-Possession-of-and-Moving-Into-New-State-of-the-Art-Manufacturing-Facility.html</link><description>HAIFA, Israel, Jan. 30, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has taken possession of and is moving into its new state-of-the-art GMP facility. The facility allows for the production of mass quantities of PLacental eXpanded (PLX) cells that possess the advantages of being...</description><pubDate>Wed, 30 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>HemoShear, LLC Relocates and Expands Operations to Historic Property in Charlottesville, Virginia  </title><link>http://www.biospace.com/news_story.aspx?StoryID=285378&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p /&gt;&lt;p /&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHARLOTTESVILLE, Va.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 22, 2013&lt;/span&gt; /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for drug development and discovery, today announced that it will expand and relocate its operations to downtown &lt;span class"xn-location"&gt;Charlottesville...</description><pubDate>Tue, 22 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Columbia Laboratories, Inc. to Relocate to Boston Area  </title><link>http://www.bizjournals.com/boston/blog/bioflash/2013/01/columbia-labs-to-relocate-to-boston-area.html?ana=otj</link><description>Columbia Laboratories Inc. (Nasdaq: CBRX), a maker of topical hormone products, plans to relocate operations to the Boston area to accommodate the companys CEO and newly hired CFO, who live in the area. The company currently has about 12 employees at its current headquarters in Livingston, New Jersey. Columbia Labs will be looking to make some hires in the Boston-area, because some of the workers...</description><pubDate>Fri, 18 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Amgen Invests $200 Million in Singapore Monoclonal Antibody Facility  </title><link>http://www.biospace.com/news_story.aspx?StoryID=285027&amp;full=1</link><description>THOUSAND OAKS, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 16, 2013&lt;/span&gt; /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of &lt;span class"xn-location"&gt;Singapore&lt;/span&gt;. Over the next several years, Amgen anticipates investing approximately &lt;span class"xn-money"&gt;$200 million&lt;/span&gt; to build an innovative new facility...</description><pubDate>Thu, 17 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Collegium Pharmaceutical, Inc. Announces Relocation to Massachusetts  </title><link>http://www.biospace.com/news_story.aspx?StoryID=285105&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CANTON, Mass.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 17, 2013&lt;/span&gt; /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to &lt;span class"xn-location"&gt;Canton, Massachusetts...</description><pubDate>Thu, 17 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Almac Group Doubles Drug Product Development Capacity With a New Non-GMP Facility  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284616&amp;full=1</link><description>14th January 2013: Almac is pleased to announce the expansion of our drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at our UK headquarters in Craigavon. The new facilities double our current pharmaceutical development capacity allowing us to meet the growing demand for our services, both from existing...</description><pubDate>Mon, 14 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Oxyrane Establishes US Operation; Brings on Board Senior Commercial, Regulatory and Clinical Team  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130114005622&amp;newsLang=en</link><description>MANCHESTER, England--(BUSINESS WIRE)--Oxyrane, a privately-owned biotechnology company with a head office in Manchester, (England) and research operations in Gent, (Belgium), announced today that it has opened a new operation in Burlington, Massachusetts (USA). The new operation is an important step in the companys evolution as it progresses clinical development of its innovative enzyme replacement...</description><pubDate>Mon, 14 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Pall Corporation Magnifies Focus on Instrumentation With Expansion of Menlo Park Facility  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130110006122&amp;newsLang=en</link><description>PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today announced that it has expanded its Menlo Park, California facility, the site of its ForteBio operations, to create a Center of Excellence (COE) for Instrumentation. The expanded COE, located in the heart of the Silicon Valley/Bay area, occupies more than 42,000 sq...</description><pubDate>Fri, 11 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Celerion Builds on Respiratory Capabilities With the Addition of an On-Site Bronchoscopy Suite  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130109005142&amp;newsLang=en</link><description>LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, the premier provider of innovative early stage drug development solutions, announces the expansion of its capabilities in the respiratory therapeutic area, with the addition of a dedicated Bronchoscopy Suite in the Belfast, Northern Ireland, UK facility. The Bronchoscopy Suite allows bronchoalveolar lavage (BAL) to be performed within the Celerion clinic utilizing...</description><pubDate>Wed, 09 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Marken&lt;/b&gt; Opens Expanded Pharmaceutical Depot in Mexico City  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284189&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RESEARCH TRIANGLE PARK, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 8, 2013&lt;/span&gt; /PRNewswire/ -- Marken announced today the completion of its new, expanded pharmaceutical depot in &lt;span class"xn-location"&gt;Mexico City&lt;/span&gt;. The new state of the art facility is located closer to the &lt;span class"xn-location"&gt;Mexico City&lt;/span&gt; airport and provides...</description><pubDate>Tue, 08 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>VIVUS, Inc. Quietly Rents Big New Headquarters  </title><link>http://www.bizjournals.com/sanjose/blog/2013/01/vivus-inc-signs-for-big-new.html?ana=yfcpc</link><description>Vivus Inc., a Mountain View drug maker with several promising treatments in the pipeline, has just signed for a big new headquarters space in the city. Vivus is taking 45,240 square feet at 351 East Evelyn Ave. in Mountain View. The company signed an 84-month lease with landlord SFERS Real Estate Corp. U, which appears to be a subsidiary of RREEF Real Estate, according to California incorporation documents...</description><pubDate>Fri, 04 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Novartis AG to Remake Horsham Site  </title><link>http://www.wscountytimes.co.uk/news/local/demolition-plans-for-horsham-novartis-site-what-do-you-think-1-4621722</link><description>The pharmaceutical giant Novartis has published its plans to start redevelopment of its Horsham site. In August the County Times exclusively revealed that the company had decided to sell a significant part of its town campus in Wimblehurst Road, but confirmed its plans to lead world class respiratory research and associated development teams in Horsham. Last week a planning application was submitted...</description><pubDate>Fri, 28 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Pluristem Therapeutics Initiates Final Validation of New Manufacturing Facility  </title><link>http://www.globenewswire.com/news-release/2012/12/27/513598/10016623/en/Pluristem-Initiates-Final-Validation-of-New-Manufacturing-Facility.html</link><description>HAIFA, Israel, Dec. 27, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has initiated the final validation steps for its new "state-of-the-art" manufacturing facility prior to taking possession of the facility. These steps include the validation of several installation systems including as heating...</description><pubDate>Thu, 27 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>ChinaBio(R) LLC Release: India to Open Drug Inspection Office in China  </title><link>http://www.chinabiotoday.com/articles/20121226</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;December 26, 2012 -- India announced it will locate its own drug inspection office in China in March of 2013, complete with four full-time inspectors. It will be India's first foreign drug office in any country. The Beijing-located operation, which will be in charge of inspecting China manufacturing facilities that export products to India and the medical products...</description><pubDate>Thu, 27 Dec 2012 12:00:00 AM GMT</pubDate></item></channel></rss>